Detalhe da pesquisa
1.
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study.
Jpn J Clin Oncol
; 54(5): 562-568, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271177
2.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Cancer Invest
; 40(2): 199-209, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894960
3.
Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists.
Nutr Cancer
; 74(7): 2392-2399, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856863
4.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703239
5.
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Cancer Invest
; 39(6-7): 473-481, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014777
6.
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Eur J Cancer Care (Engl)
; 29(6): e13296, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864838
7.
Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.
World J Surg Oncol
; 17(1): 50, 2019 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871581
8.
BRCA mutations in women with inflammatory breast cancer.
Cancer
; 124(3): 466-474, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044548
9.
Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study.
J BUON
; 22(1): 208-213, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28365956
10.
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
J Gastrointest Cancer
; 53(2): 282-288, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538958
11.
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.
Tumori
; 107(5): 416-423, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167790
12.
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
J Cancer Res Clin Oncol
; 147(7): 2145-2152, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33433657
13.
The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.
Eur J Surg Oncol
; 46(3): 402-409, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955995
14.
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Balkan Med J
; 37(2): 104-107, 2020 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31970972
15.
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.
Eur J Breast Health
; 14(3): 160-165, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30123882
16.
Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].
Eur J Surg Oncol
; 46(9): 1774, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32800281